Sign in
ELOX Stock Price, Chart, Stats & News
Eloxx Pharmaceuticals, Inc.
Save
Eloxx Pharmaceuticals, Inc. (ELOX) does not currently pay a dividend.
51.65M
Market cap
4.27x
Current P/E
–
Forward P/E
ELOX chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -113.76% |
ROE | 53.13% |
D/E | -0.08x |
Interest coverage ratio | -6.14x |
ELOX valuation
P/E | 4.27x |
P/S | – |
P/B | -0.20x |
P/CF | -0.37x |
P/FCF | -0.10x |
P/OCF | -0.37x |
PEG | -0.00x |
EV multiple | -0.69x |
About
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-rare genetic diseases that arise from premature stop codons. The company's most advanced investigational compound, ELX-02, is currently progressing through Phase 2 clinical trials.
Similar securities
Based on sector and market capitalization
Report issue